RxDoctor Payments Data

Szilard Voros

Cardiovascular Disease · Stony Brook, NYNPI 1831233576

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $3,438,380 of the $3,664,765 with a category attached, or 93.8%. Every reported general payment came from a single manufacturer, Novartis. Among cardiovascular disease clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,664,765in general payments, 2019–2025

Across 18 payments — averaging $203,598 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$3.7M
$11,248in research payments, 2019–2025

Across 4 payments — averaging $2812.08 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novartis$11K

What the payments were for

  • Consulting fees$226,0636%
  • Speaking & faculty fees$3,438,38094%
  • Food & beverage$3230%

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis18$3,664,765

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,664,765 in reported general payments places this provider in the 95th percentile of 2,302 cardiovascular disease providers in New York.

See all cardiovascular disease providers in New York →

Other cardiovascular disease in Stony Brook

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →